Who owns Liminatus Pharma Inc A?
- Ticker: LIMN
- CUSIP Number: 53271x108
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma Inc A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Liminatus Pharma Inc A stock
Who bought or sold Liminatus Pharma Inc A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 678k | $117k | 855% | Mar 2026 |
|
| Cygnus Capital Advisors | 350k | $60k | 100% | Mar 2026 |
|
| Geode Capital Management | 118k | $20k | 81% | Mar 2026 |
|
| Jane Street | 71k | $12k | 100% | Mar 2026 |
|
| UBS Group | 55k | $9.4k | 181% | Mar 2026 |
|
| Vanguard Capital Management | 50k | $8.7k | 100% | Mar 2026 |
|
| JustInvest | 35k | $6.0k | 100% | Mar 2026 |
|
| Virtu Financial | 28k | $5.0k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 23k | $4.0k | 100% | Mar 2026 |
|
| Two Sigma Securities | 22k | $3.8k | 86% | Mar 2026 |
|
| State Street Corporation | 19k | $3.3k | 0% | Mar 2026 |
|
| BlackRock | 13k | $2.3k | 0% | Mar 2026 |
|
| Tower Research Capital | 7.6k | $1.3k | -15% | Mar 2026 |
|
| Citigroup | 6.8k | $1.2k | 100% | Mar 2026 |
|
Who sold out of Liminatus Pharma Inc A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Dec 2025 | 35k | $22k |